Home/Blogs/Blog details

The first ever successful treatment on Congenitaldyserythropoieticanemia (CDA), a rare blood disorder

Mar 23, 2017

The first ever successful treatment on Congenitaldyserythropoieticanemia (CDA), a rare blood disorder

Congenital dyserythropoieticanemia(CDA) is a rarest blood disease, alike thalassemia. CDA is one of the several types of anemia which is categorized by inefficient erythropoiesis. It also is a resultant from a descending number of red blood cells (RBCs) in the human body and a decreases hemoglobin levels in the blood. The human body fails to generate enough red blood cells, thereby resulting in progressive organ damage and even early death. In of the first such cases recorded, doctors at the University of Illinois Hospital & Health Sciences System have furnished and authenticated the first cure of an adult patient who was suffering from congenital dyserythropoieticanemia. It is a procedure which prevent from the usage of extremely high dosage of radiation and chemotherapy in prepping up for a stem cell transplant. The transplant procedure used is exclusive, since it enables a donor’s cells to slowly adopt and invade into a patient’s bone marrow without making use of any harmful toxicant to kill a patient’s cells before the transplant. The Michael Reese Professor of Hematology at the University of Illinois at Chicago, Dr. Damian Rondellisays that this procedure can be used even in patients whohave a prolonged genetics of disease and already have a few damaged organs owing to the very minimum use of chemotherapy. According to Rondelli, many patients who have blood disorders, the treatment options have always remained limited since they are oftentimes do not possess symptoms severe enough to qualify for the such a risky procedure, or the patients are extremely incapable of tolerating the toxic drugs which are prescribed beside a standard transplantation procedure.Also, this procedure renders the potential option of a stem cell transplant which was earlier not an option for a few adults. One proven Case Almost more than 30 years, David Levy from Northbrook, Illinois who was 24 back then had a regular blood transfusion to ascertain that his tissues and organs received ample oxygen.By the age 32, Levy’s condition needed transfusions every two to three weeks, he has already damaged spleen, his liver had enlarged and was going through extreme fatigue, iron poisoning and palpitations, all of which are side effects of frequent blood transfusions. Many medical institutions had denied Levy a stem cell transplant because of his range of illnesses and unfitness to endure radiation and chemotherapy. In 2014, Dr.Rondelliperformed the procedure on Levy. The transplant procedure was not easy and he did have some complications, however he is back to normal now.Levy who is now 35 says that he still has some hovering troubles from the years of mismanagement of the disorder, but he is independent and recovering now.Rondelli feels that the possibility of this technique to stem cell transplantation is quite assuring and might signify therapeutic strategy for the treatment of adult patients who have several types of congenital anemias.

footer pattern

All Copyrights reserve worldhealthcarenews.biz 2017.